What is the projected market valuation of the Novolac Resin Market by 2035?

The Novolac Resin Market is projected to reach a valuation of 5.005 USD Billion by 2035. Read More

What was the market valuation of the Novolac Resin Market in 2024?

In 2024, the Novolac Resin Market was valued at 3.36 USD Billion. Read More

What is the expected CAGR for the Novolac Resin Market during the forecast period 2025 - 2035?

The expected CAGR for the Novolac Resin Market during the forecast period 2025 - 2035 is 3.69%. Read More

Which application segment is projected to have the highest valuation by 2035?

The Electrical Laminates application segment is projected to reach a valuation of 1.58 USD Billion by 2035. Read More

What are the projected valuations for the Adhesives and Composites segments by 2035?

Both the Adhesives and Composites segments are projected to reach valuations of 0.95 USD Billion by 2035. Read More

Which end-use industry is expected to dominate the Novolac Resin Market by 2035?

The Electronics end-use industry is expected to dominate, with a projected valuation of 1.8 USD Billion by 2035. Read More

What is the projected market size for Phenolic Novolac Resins by 2035?

The market size for Phenolic Novolac Resins is projected to reach 1.95 USD Billion by 2035. Read More

Which key players are leading the Novolac Resin Market?

Key players in the Novolac Resin Market include Hexion Inc, BASF SE, and Momentive Performance Materials Inc. Read More

What is the projected valuation for the Automotive end-use industry by 2035?

The Automotive end-use industry is projected to reach a valuation of 1.2 USD Billion by 2035. Read More

What are the projected valuations for the Curing Agents segment by 2035?

The Curing Agents segment is projected to reach valuations of 1.45 USD Billion for Hexamethylenetetramine and Methyl Alcohol by 2035. Read More

Novolac Resin Market

ID: MRFR/CnM/39874-HCR

111 Pages

Chitranshi Jaiswal

Last Updated: April 06, 2026

Novolac Resin Market Research Report: By Application (Coatings, Adhesives, Composites, Electrical Laminates), By End Use Industry (Automotive, Construction, Consumer Goods, Electronics), By Formulation Type (Phenolic Novolac Resins, Modified Novolac Resins, Thermosetting Novolac Resins), By Curing Agent (Hexamethylenetetramine, Methyl Alcohol, Amines) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Chemicals and Materials, BY Application (USD Billion)
4.1.1 Coatings
4.1.2 Adhesives
4.1.3 Composites
4.1.4 Electrical Laminates
4.2 Chemicals and Materials, BY End Use Industry (USD Billion)
4.2.1 Automotive
4.2.2 Construction
4.2.3 Consumer Goods
4.2.4 Electronics
4.3 Chemicals and Materials, BY Formulation Type (USD Billion)
4.3.1 Phenolic Novolac Resins
4.3.2 Modified Novolac Resins
4.3.3 Thermosetting Novolac Resins
4.4 Chemicals and Materials, BY Curing Agent (USD Billion)
4.4.1 Hexamethylenetetramine
4.4.2 Methyl Alcohol
4.4.3 Amines
4.5 Chemicals and Materials, BY Region (USD Billion)
4.5.1 North America
4.5.1.1 US
4.5.1.2 Canada
4.5.2 Europe
4.5.2.1 Germany
4.5.2.2 UK
4.5.2.3 France
4.5.2.4 Russia
4.5.2.5 Italy
4.5.2.6 Spain
4.5.2.7 Rest of Europe
4.5.3 APAC
4.5.3.1 China
4.5.3.2 India
4.5.3.3 Japan
4.5.3.4 South Korea
4.5.3.5 Malaysia
4.5.3.6 Thailand
4.5.3.7 Indonesia
4.5.3.8 Rest of APAC
4.5.4 South America
4.5.4.1 Brazil
4.5.4.2 Mexico
4.5.4.3 Argentina
4.5.4.4 Rest of South America
4.5.5 MEA
4.5.5.1 GCC Countries
4.5.5.2 South Africa
4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Chemicals and Materials
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Hexion Inc (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 BASF SE (DE)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Momentive Performance Materials Inc (US)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 SABIC (SA)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Mitsui Chemicals Inc (JP)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 DIC Corporation (JP)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Kraton Corporation (US)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Ashland Global Holdings Inc (US)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 Huntsman Corporation (US)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY APPLICATION
6.4 US MARKET ANALYSIS BY END USE INDUSTRY
6.5 US MARKET ANALYSIS BY FORMULATION TYPE
6.6 US MARKET ANALYSIS BY CURING AGENT
6.7 CANADA MARKET ANALYSIS BY APPLICATION
6.8 CANADA MARKET ANALYSIS BY END USE INDUSTRY
6.9 CANADA MARKET ANALYSIS BY FORMULATION TYPE
6.10 CANADA MARKET ANALYSIS BY CURING AGENT
6.11 EUROPE MARKET ANALYSIS
6.12 GERMANY MARKET ANALYSIS BY APPLICATION
6.13 GERMANY MARKET ANALYSIS BY END USE INDUSTRY
6.14 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
6.15 GERMANY MARKET ANALYSIS BY CURING AGENT
6.16 UK MARKET ANALYSIS BY APPLICATION
6.17 UK MARKET ANALYSIS BY END USE INDUSTRY
6.18 UK MARKET ANALYSIS BY FORMULATION TYPE
6.19 UK MARKET ANALYSIS BY CURING AGENT
6.20 FRANCE MARKET ANALYSIS BY APPLICATION
6.21 FRANCE MARKET ANALYSIS BY END USE INDUSTRY
6.22 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
6.23 FRANCE MARKET ANALYSIS BY CURING AGENT
6.24 RUSSIA MARKET ANALYSIS BY APPLICATION
6.25 RUSSIA MARKET ANALYSIS BY END USE INDUSTRY
6.26 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE
6.27 RUSSIA MARKET ANALYSIS BY CURING AGENT
6.28 ITALY MARKET ANALYSIS BY APPLICATION
6.29 ITALY MARKET ANALYSIS BY END USE INDUSTRY
6.30 ITALY MARKET ANALYSIS BY FORMULATION TYPE
6.31 ITALY MARKET ANALYSIS BY CURING AGENT
6.32 SPAIN MARKET ANALYSIS BY APPLICATION
6.33 SPAIN MARKET ANALYSIS BY END USE INDUSTRY
6.34 SPAIN MARKET ANALYSIS BY FORMULATION TYPE
6.35 SPAIN MARKET ANALYSIS BY CURING AGENT
6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
6.37 REST OF EUROPE MARKET ANALYSIS BY END USE INDUSTRY
6.38 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE
6.39 REST OF EUROPE MARKET ANALYSIS BY CURING AGENT
6.40 APAC MARKET ANALYSIS
6.41 CHINA MARKET ANALYSIS BY APPLICATION
6.42 CHINA MARKET ANALYSIS BY END USE INDUSTRY
6.43 CHINA MARKET ANALYSIS BY FORMULATION TYPE
6.44 CHINA MARKET ANALYSIS BY CURING AGENT
6.45 INDIA MARKET ANALYSIS BY APPLICATION
6.46 INDIA MARKET ANALYSIS BY END USE INDUSTRY
6.47 INDIA MARKET ANALYSIS BY FORMULATION TYPE
6.48 INDIA MARKET ANALYSIS BY CURING AGENT
6.49 JAPAN MARKET ANALYSIS BY APPLICATION
6.50 JAPAN MARKET ANALYSIS BY END USE INDUSTRY
6.51 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
6.52 JAPAN MARKET ANALYSIS BY CURING AGENT
6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
6.54 SOUTH KOREA MARKET ANALYSIS BY END USE INDUSTRY
6.55 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE
6.56 SOUTH KOREA MARKET ANALYSIS BY CURING AGENT
6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION
6.58 MALAYSIA MARKET ANALYSIS BY END USE INDUSTRY
6.59 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE
6.60 MALAYSIA MARKET ANALYSIS BY CURING AGENT
6.61 THAILAND MARKET ANALYSIS BY APPLICATION
6.62 THAILAND MARKET ANALYSIS BY END USE INDUSTRY
6.63 THAILAND MARKET ANALYSIS BY FORMULATION TYPE
6.64 THAILAND MARKET ANALYSIS BY CURING AGENT
6.65 INDONESIA MARKET ANALYSIS BY APPLICATION
6.66 INDONESIA MARKET ANALYSIS BY END USE INDUSTRY
6.67 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE
6.68 INDONESIA MARKET ANALYSIS BY CURING AGENT
6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION
6.70 REST OF APAC MARKET ANALYSIS BY END USE INDUSTRY
6.71 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE
6.72 REST OF APAC MARKET ANALYSIS BY CURING AGENT
6.73 SOUTH AMERICA MARKET ANALYSIS
6.74 BRAZIL MARKET ANALYSIS BY APPLICATION
6.75 BRAZIL MARKET ANALYSIS BY END USE INDUSTRY
6.76 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE
6.77 BRAZIL MARKET ANALYSIS BY CURING AGENT
6.78 MEXICO MARKET ANALYSIS BY APPLICATION
6.79 MEXICO MARKET ANALYSIS BY END USE INDUSTRY
6.80 MEXICO MARKET ANALYSIS BY FORMULATION TYPE
6.81 MEXICO MARKET ANALYSIS BY CURING AGENT
6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION
6.83 ARGENTINA MARKET ANALYSIS BY END USE INDUSTRY
6.84 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE
6.85 ARGENTINA MARKET ANALYSIS BY CURING AGENT
6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE INDUSTRY
6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE
6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY CURING AGENT
6.90 MEA MARKET ANALYSIS
6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
6.92 GCC COUNTRIES MARKET ANALYSIS BY END USE INDUSTRY
6.93 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE
6.94 GCC COUNTRIES MARKET ANALYSIS BY CURING AGENT
6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
6.96 SOUTH AFRICA MARKET ANALYSIS BY END USE INDUSTRY
6.97 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE
6.98 SOUTH AFRICA MARKET ANALYSIS BY CURING AGENT
6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION
6.100 REST OF MEA MARKET ANALYSIS BY END USE INDUSTRY
6.101 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE
6.102 REST OF MEA MARKET ANALYSIS BY CURING AGENT
6.103 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
6.104 RESEARCH PROCESS OF MRFR
6.105 DRO ANALYSIS OF CHEMICALS AND MATERIALS
6.106 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
6.107 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
6.108 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
6.109 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
6.110 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Billion)
6.111 CHEMICALS AND MATERIALS, BY END USE INDUSTRY, 2024 (% SHARE)
6.112 CHEMICALS AND MATERIALS, BY END USE INDUSTRY, 2024 TO 2035 (USD Billion)
6.113 CHEMICALS AND MATERIALS, BY FORMULATION TYPE, 2024 (% SHARE)
6.114 CHEMICALS AND MATERIALS, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
6.115 CHEMICALS AND MATERIALS, BY CURING AGENT, 2024 (% SHARE)
6.116 CHEMICALS AND MATERIALS, BY CURING AGENT, 2024 TO 2035 (USD Billion)
6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
7.2.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.2.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.2.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
7.3.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.3.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.3.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
7.4.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.4.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.4.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
7.5.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.5.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.5.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
7.6.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.6.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.6.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
7.7.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.7.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.7.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
7.8.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.8.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.8.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
7.9.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.9.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.9.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
7.10.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.10.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.10.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
7.11.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.11.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.11.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
7.12.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.12.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.12.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
7.13.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.13.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.13.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
7.14.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.14.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.14.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
7.15.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.15.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.15.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
7.16.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.16.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.16.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
7.17.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.17.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.17.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
7.18.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.18.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.18.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
7.19.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.19.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.19.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
7.20.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.20.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.20.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
7.21.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.21.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.21.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
7.22.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.22.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.22.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
7.23.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.23.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.23.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
7.24.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.24.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.24.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
7.25.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.25.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.25.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
7.26.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.26.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.26.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
7.27.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.27.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.27.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
7.28.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.28.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.28.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
7.29.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.29.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.29.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
7.30.2 BY END USE INDUSTRY, 2025-2035 (USD Billion)
7.30.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.30.4 BY CURING AGENT, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Chemicals and Materials Market Segmentation

Chemicals and Materials By Application (USD Billion, 2025-2035)

Coatings
Adhesives
Composites
Electrical Laminates

Chemicals and Materials By End Use Industry (USD Billion, 2025-2035)

Automotive
Construction
Consumer Goods
Electronics

Chemicals and Materials By Formulation Type (USD Billion, 2025-2035)

Phenolic Novolac Resins
Modified Novolac Resins
Thermosetting Novolac Resins

Chemicals and Materials By Curing Agent (USD Billion, 2025-2035)

Hexamethylenetetramine
Methyl Alcohol
Amines

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓